JPMorgan Chase & Co’s Can-Fite BioPharma CANF Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-460	Closed	-$1.22K	–	6489
2023 Q3	$1.22K	Buy	+460	New	+$1.22K	﹤0.01%	5660
2023 Q2	–	Sell	-100	Closed	–	–	6010
2023 Q1	$0	Buy	+100	New	–	﹤0.01%	5817